Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 4Unknown 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 3Infections 2Urinary Tract Infections 1Ureteral Obstruction 1Neoplasms 1Acute Kidney Injury 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Antibiotic Prophylaxis × Clear all
NCT06801405 2026-05-19

Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction

Barretos Cancer Hospital

Completed
320 enrolled 6 charts
Genitourinary

Neoplasms, Ureteral Obstruction, Urinary Tract Infections, Acute Kidney Injury

NCT04815876 2026-02-20

PREVENT2

Weill Medical College of Cornell University

Phase NA Completed
1,030 enrolled
Genitourinary

Infections, Prostatic Neoplasms

NCT04843566 2025-04-15

PREVENT

Weill Medical College of Cornell University

Phase NA Completed
687 enrolled 11 charts
Genitourinary

Infections, Prostatic Neoplasms

NCT04146142 2021-12-07

NORAPP

Oslo University Hospital

Phase NA Completed
550 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡